A nationwide clinical trial is underway to determine if a specialized drink is able to improve the neurocognitive deficits seen in Alzheimer dementia (AD). The tested concoction is being evaluated for its ability to provide improvement in the clinical domain of verbal recall. The trial is based upon a European study done in which 225 AD patients were randomized to take the nutritive drink or a placebo. Results were apparently encouraging^[1] enough to U.S. researchers to enroll patients at 40 sites across the U.S. in a double-blinded study. Should be interesting.

I guess you could call it a kind of Boost for dementia.

1. In that study, 225 patients with mild Alzheimer’s were divided into two groups. Some drank Souvenaid and the others sipped a non-medical drink every day for 12 weeks. Researchers found that the patients who drank Souvenaid improved in a delayed verbal recall task. [↩]

Related Posts Within Doctor Pundit:

1. Study: Anti-Inflammatory Painkillers Not Seen as Protective against Dementia Development Nothing, it seems, lends itself to the aphorism that if-one-doesn’t-like-the-results-of-some-medical-trial-just-wait-a-few-and-you’ll-be-rewarded...
2. Study: Authors Attempt to Characterize Dementia As a Terminal Illness In the upcoming NEJM, a large prospective study makes the...
3. Study: Spouses of Dementia Patients May Be at Increased Risk of Incident Dementia Although the prevalence rate of dementia is higher overall in...